Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma

NCT02774421 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Posterior Fossa Ependymoma (PFEPN)

Interventions

DRUG: Trastuzumab after SubQ GM-CSF
DRUG: Trastuzumab in combination with SubQ GM-CSF

Sponsor

University of Colorado, Denver

Collaborators

[object Object]